España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sangamo Therapeutics
SGMO
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$0.322500
0.0005
0.16%
At Close: -
$0.328800
0.0063
1.95%
After Hours: 7:59 PM EDT
15 minutes delayed
Get Report
Watch
Sangamo Therapeutics (SGMO) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Sangamo Therapeutics (NASDAQ:SGMO) Stock
Sangamo Therapeutics Stock (NASDAQ: SGMO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Thursday, May 09, 2024
Sangamo Therapeutics Q1 2024 GAAP EPS $(0.27)...
Benzinga Newsdesk
Sangamo Therapeutics Presents Modular Integra...
Benzinga Newsdesk
Monday, April 22, 2024
Sangamo Therapeutics To Present Neurology-Foc...
Benzinga Newsdesk
Friday, March 22, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Sangamo Therapeutics shares are trading lower...
Benzinga Newsdesk
Sangamo Therapeutics Announces Pricing Of $24M Registered Direct Offering
Happy Mohamed
Tuesday, March 19, 2024
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Thursday, March 14, 2024
RBC Capital Reiterates Sector Perform on Sang...
Benzinga Newsdesk
Wednesday, March 13, 2024
4 Analysts Assess Sangamo Therapeutics: What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Sangamo ...
Benzinga Newsdesk
Sangamo Therapeutics Expects Total Operating ...
Benzinga Newsdesk
Sangamo Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate, Sales $2.04M Miss $8.10M Estimate
Happy Mohamed
Sangamo Therapeutics Announces Data From STAC...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Monday, February 12, 2024
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Sangamo Therapeutics shares are trading highe...
Benzinga Newsdesk
Sangamo Therapeutics Announces FDA Alignment ...
Benzinga Newsdesk
Tuesday, February 06, 2024
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, February 05, 2024
Sangamo Therapeutics Reports Updated Prelimin...
Benzinga Newsdesk
Sangamo Therapeutics Gets European Medicines ...
Benzinga Newsdesk
Friday, January 19, 2024
Deep Dive Into Sangamo Therapeutics Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Sangamo...
Benzinga Newsdesk
Wednesday, January 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Wednesday, November 15, 2023
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Tuesday, November 07, 2023
Truist Securities Downgrades Sangamo Therapeu...
Benzinga Newsdesk
Monday, November 06, 2023
Where Sangamo Therapeutics Stands With Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Sangamo ...
Benzinga Newsdesk
What 8 Analyst Ratings Have To Say About Sangamo Therapeutics
Benzinga Insights
Wells Fargo Downgrades Sangamo Therapeutics t...
Benzinga Newsdesk
Friday, November 03, 2023
Sangamo Therapeutics Inc Says Pfizer Expects ...
Benzinga Newsdesk
What To Know About RBC Capital's Downgrade of Sangamo Therapeutics
Benzinga Insights
RBC Capital Downgrades Sangamo Therapeutics t...
Benzinga Newsdesk
Thursday, November 02, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Sangamo Therapeutics shares are trading lower...
Benzinga Newsdesk
Wednesday, November 01, 2023
Sangamo Therapeutics Q3 EPS $(0.59) Misses $(...
Benzinga Newsdesk
Earnings Scheduled For November 1, 2023
Benzinga Insights
Tuesday, October 24, 2023
Sangamo Therapeutics To Present Pre-Clinical ...
Benzinga Newsdesk
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, September 29, 2023
Sangamo Therapeutics 10% Owner Sold $3.00M In Company Stock
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, August 31, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch